Activity of posaconazole in the treatment of central nervous system fungal infections (Q36246196)

13 August 2017

Activity of posaconazole in the treatment of central nervous system fungal infections (English)

1 reference

13 August 2017

0 references

5

Peter Pappas

1 reference

13 August 2017

Punnee Pitisuttithum

1

1 reference

13 August 2017

Ricardo Negroni

2

1 reference

13 August 2017

John R Graybill

3

1 reference

13 August 2017

Beatriz Bustamante

4

1 reference

13 August 2017

Stanley Chapman

6

1 reference

13 August 2017

Roberta S Hare

7

1 reference

13 August 2017

Catherine J Hardalo

8

1 reference

13 August 2017

language of work or name

English

0 references

publication date

31 August 2005

1 reference

Journal of Antimicrobial Chemotherapy

13 August 2017

1 reference

13 August 2017

56

1 reference

13 August 2017

745-755

1 reference

13 August 2017

4

1 reference

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America

13 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Opportunistic CNS infection after bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Treatment of Scedosporium apiospermum brain abscesses with posaconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Cryptococcal meningitis and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Zygomycetes in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

In vitro susceptibilities of zygomycetes to conventional and new antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

In vitro and in vivo activities of posaconazole against Coccidioides immitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

In vitro activities of four novel triazoles against Scedosporium spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Activity of posaconazole against Pseudallescheria boydii: in vitro and in vivo assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Laboratory evaluation of new antifungal agents against rare and refractory mycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Efficacy of SCH56592 in a rabbit model of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Posaconazole therapy for systemic coccidioidomycosis in a chimpanzee (Pan troglodytes): a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Nonvalue of culturing cerebrospinal fluid for fungi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Antifungal susceptibilities of Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

Primary central nervous system phaeohyphomycosis: a review of 101 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI288

21 January 2018

Identifiers

DOI

10.1093/JAC/DKI288

1 reference

13 August 2017

1 reference